Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.
Asana reported quarterly losses of 4 cents per share which beat the analyst consensus estimate of losses of 10 cents by 60%. Quarterly sales came in at $171.1 million, beating the analyst consensus estimate of $167.676 million by 2.04%.
The company expects fiscal year 2025 adjusted losses of between 22 cents and 19 cents per share, versus the losses of 22 cents estimate and fiscal year revenues of between $716 million and $722 million, versus the $724.75 estimate.
Asana shares dipped 11% to $16.72 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers
ClearOne, Inc. (NASDAQ: CLRO) rose 168.4% to $2.4299. ClearOne announced a special one-time cash dividend of 50 cents per share.
Regulus Therapeutics Inc. (NASDAQ: RGLS) climbed 74.3% to $2.4050 after the company announced topline results from the second cohort of patients in its Phase 1b MAD study of RGLS8429 for the treatment of ADPKD. The company announced an oversubscribed $100 million private placement of equity.
Assure Holdings Corp. (NASDAQ: IONM) gained 49% to $0.4880. Assure Holdings entered into an agreement to sell certain of its assets to MPOWERHealth for up to $4.5 million.
Ranpak Holdings Corp. (NASDAQ: PACK) shares gained 40.1% to $6.12 after the company reported better-than-expected fourth-quarter revenue results and issued FY24 guidance. Also, Baird maintained an Outperform rating on the stock and raised its price target from $5 to $7.
Singularity Future Technology Ltd. (NASDAQ: SGLY) climbed 37.6% to $4.3321 after gaining over 6% on Monday.
Li-Cycle Holdings Corp. (NASDAQ: LICY) gained 27.4% to $0.5111 after the company entered an agreement to issue a senior secured convertible note in an aggregate principal amount of $75 million to an affiliate of Glencore.
Nukkleus Inc. (NASDAQ: NUKK) shares rose 22.5% to $1.41 after surging over 43% on Monday.
ATRenew Inc. (NYSE: RERE) gained 17.7% to $1.4003 after the company ...
Benzinga
